Focus on Gynecologic Cancers: 3rd Annual Conference

Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 3 de febrero del 2002

Share article


English

Date: Friday, April 26, 2002
Location: Adams Mark Hotel, City Line and Monument Road, Philadelphia, Pennsylvania, USA


Sponsors: The University of Pennsylvania Cancer Center

Who Should Attend: Women Whose Lives have Been Touched by Gynecologic Cancer

Conference Objectives: Learn about the latest advances in diagnosis, surgical and medical treatment options, clinical trials and genetics for various gynecological cancers including: ovarian, uterine, cervical, vaginal, and vulvar.

Learn about the causes of the physical side effects that may accompany gynecologic cancer and its treatment, and obtain information on the latest advances in the treatment of pelvic pain, urinary incontinence, peripheral neuropathy, fatigue and lymphedema.

Obtain the most recent information on treatment options and advances in radiation therapy for gynecological cancers.

Conference Agenda:

  • 8:00 AM to 4:00 PM
  • 8:00 AM Registration and Continental Breakfast
  • 9:00 AM Welcome and Introduction: Stephen Rubin, MD
  • 9:15-10:45 AM Overview of Gynecologic Cancers: Stephen Rubin, MD and Mark Morgan, MD
  • 10:45-11:00 AM Break
  • 11:00-11:30 AM The Role of Radiation Therapy in the Treatment of Gynecological Cancers: Eleanor Harris, MD
  • 11:30 AM-12:15 PM How has my body changed?: Andrea Cheville MD
  • 12:15-12:45 PM Experts Panel on Gynecological Cancers: Stephen Rubin, MD, Mark Morgan, MD, Eleanor Harris, MD and Andrea Cheville, MD
  • 12:45-1:30 PM Luncheon
  • 1:30-2:00 PM Keynote Address--Advocacy for Women's Health: Applying Advocacy Principles to the Gynecologic Cancer Experience: State Senator Allyson Y. Schwartz

Workshop Sessions: Each workshop will be offered twice (2:15-3:00 PM and 3:00-3:45 PM)

Reclaiming Your Sexual Self
Andrea Cheville, MD
Lecture and discussion focused on physical changes that may accompany treatment for gynecologic cancer and affect sexual identity and comfort.

Survivor Stories
Jodi Weiner, MSW, LSW - Facilitator
A panel of women offers hope, insight and inspiration by sharing their stories of how gynecologic cancer affected their lives.

Registration Info: Registration deadline is Friday, April 19, 2002. Call 215-349-8382 or 1-800-789-PENN for more information or register online below.

Online Registration
Name:
Street
Address:

City:
State     ZIP Code:
Email Address:
Daytime Telephone #:
Number Attending:

   

Conference Faculty:

Andrea Cheville, MD
Assistant Professor, Medicine
Director, Cancer Rehabilitation
University of Pennsylvania Cancer Center

Eleanor Harris, MD
Assistant Professor, Radiation Oncology
University of Pennsylvania Cancer Center

Mark Morgan, MD
Associate Professor, Gynecologic Oncology
University of Pennsylvania Cancer Center

Stephen C. Rubin, MD
Professor, Gynecologic Oncology
Chief, Division of Gynecologic Oncology
University of Pennsylvania Cancer Center

State Senator Allyson Y. Schwartz
Allyson Y. Schwartz is the senior woman legislator in the Pennsylvania Senate. Senator Schwartz has been a leader in fighting for accessible, affordable, and high-quality health care for all Pennsylvanians. She is a strong and articulate voice for the concerns of Pennsylvania's women, children, and families. She brings a deep understanding and commitment to assuring that all women and girls have access to quality health care, including reproductive rights, and equal educational and economic opportunity. Senator Schwartz authored the provision in the Managed Care Consumer Protection Act giving women direct access to obstetricians and gynecologists. She authored the law requiring insurance coverage for annual gynecological exams and routine Pap smears, and helped to enact requirements that health insurers cover inpatient care after mastectomies, reconstructive surgery, and the cost of prosthetic devices.

The Abramson Cancer Center of the University of Pennsylvania gratefully acknowledges OrthoBiotech Oncology for their unrestricted educational grant in support of this conference.

English
News
ASCO: Gastrointestinal Cancer Treatments Analyzed

Sep 20, 2014 - In patients with synchronous stage IV colorectal cancer who receive up-front modern combination chemotherapy, immediate colon surgery to remove the primary tumor is seldom necessary, according to research presented at the annual meeting of the American Society of Clinical Oncology, held from May 29 to June 2 in Orlando, Fla. These findings accompanied several other studies presented at the conference focusing on treatment of gastrointestinal cancers.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información